ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 571,57
0,91%
Dow Jones
38 778,10
0,49%
DAX
18 068,21
0,26%
Brent Oil
83,885
-0,02%
Bitcoin
66 245,57
-0,36%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Royaume-Uni
  5. LSE
  6. Maxcyte Inc (MXCT)

  7. Maxcyte Inc (MXCT) Actualités

MXCT Maxcyte Inc

380,00
0,00 (0,00%)
17 Juin 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Maxcyte Inc MXCT London Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,00 0,00% 380,00 08:39:18
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
380,00 380,00 380,00 380,00 380,00
plus d'informations sur les cotations »
Secteur Industriel
PHARMACEUTICALS & BIOTECHNOLOGY

Actualités Recentes

Date Heure Source Titre
14/6/202408:00UK RNSMaxCyte, Inc. Grant of Options and Restricted Stock Units
12/6/202408:00UK RNSMaxCyte, Inc. Result of AGM
11/6/202412:10ALNCNewsIN BRIEF: MaxCyte CEO Maher Masoud buys 100,000 shares
11/6/202408:00UK RNSMaxCyte, Inc. PDMR Dealing
03/6/202416:22UK RNSMaxCyte, Inc. Total Voting Rights
29/5/202414:05UK RNSMaxCyte, Inc. Participation in Upcoming Investor Conference
29/5/202414:05GLOBEMaxCyte to Participate in William Blair 44th Annual Growth..
22/5/202422:51ALNCNewsIN BRIEF: MaxCyte inks deal with Legend Biotech for tech..
22/5/202414:05GLOBEMaxCyte Signs Strategic Platform License Agreement with..
22/5/202414:05UK RNSMaxCyte, Inc. Signing of Strategic Platform License
20/5/202408:00UK RNSMaxCyte, Inc. Holding(s) in Company
14/5/202415:55UK RNSMaxCyte, Inc. Holding(s) in Company
08/5/202410:46ALNCNewsMaxCyte shares rise amid double-digit revenue increase
08/5/202408:05UK RNSMaxCyte, Inc. Filing of Form 10-Q
08/5/202408:00UK RNSMaxCyte, Inc. First Quarter Results
07/5/202422:05GLOBEMaxCyte Reports First Quarter 2024 Financial Results and..
03/5/202408:00UK RNSMaxCyte, Inc. Notice of AGM
01/5/202418:04UK RNSMaxCyte, Inc. Total Voting Rights
10/4/202414:05UK RNSMaxCyte, Inc. Notice of Results
10/4/202414:05GLOBEMaxCyte to Report First Quarter 2024 Financial Results on..
03/4/202408:00UK RNSMaxCyte, Inc. Total Voting Rights and Block Listing Return
02/4/202416:19ALNCNewsTRADING UPDATES: MaxCyte inks deal with Be Bio; Orcadian..
02/4/202414:05GLOBEMaxCyte Signs Strategic Platform License with Be Biopharma..
02/4/202414:05UK RNSMaxCyte, Inc. Signing of Strategic Platform License
02/4/202408:00UK RNSMaxCyte, Inc. Exercise of options and PDMR dealing
20/3/202411:16UK RNSMaxCyte, Inc. Grant of Options, RSUs and PSUs and PDMR..
20/3/202411:05UK RNSMaxCyte, Inc. Grant of Options, RSUs and PSUs and PDMR..
13/3/202412:54ALNCNewsIN BRIEF: MaxCyte loss widens in 2023 as core revenue..
13/3/202408:05UK RNSMaxCyte, Inc. Filing of form 10-K for FY ended December 31,..
13/3/202408:00UK RNSMaxCyte, Inc. Reports Q4 & FY 2023 Financial Results
12/3/202421:05UKREGMaxCyte Reports Fourth Quarter and Full Year 2023 Financial..
06/3/202409:58UK RNSMaxCyte, Inc. TR-1: Notification of major holdings
05/3/202421:43ALNCNewsEARNINGS: dotdigital eyes rosy future; Beeks Financial turns..
05/3/202408:00UK RNSMaxCyte, Inc. Preliminary FY Results & 2024 Guidance
04/3/202422:05UKREGMaxCyte Initiates Full Year 2024 Guidance and Reaffirms 2023..
01/3/202418:57UK RNSMaxCyte, Inc. Total Voting Rights
29/2/202410:21UK RNSMaxCyte, Inc. Exercise of options and PDMR dealing
26/2/202408:00UK RNSMaxCyte, Inc. TR-1: Notification of major holdings
09/2/202414:05UK RNSMaxCyte, Inc. Notice of Results
09/2/202414:05UKREGMaxCyte to Report Fourth Quarter and Full Year 2023..
01/2/202410:24UK RNSMaxCyte, Inc. Total Voting Rights
31/1/202408:00UK RNSMaxCyte, Inc. Director/PDMR Shareholding
30/1/202415:29UK RNSMaxCyte, Inc. Holding(s) in Company
30/1/202414:58ALNCNewsIN BRIEF: MaxCyte signs licencing deal with cell therapy..
30/1/202414:05UKREGMaxCyte and Wugen Sign Strategic Platform License to..
30/1/202414:05UK RNSMaxCyte, Inc. Signing of Strategic Platform License
29/1/202418:56ALNCNewsIN BRIEF: MaxCyte chief scientific officer leaves firm
29/1/202417:52UK RNSMaxCyte, Inc. TR-1: Notification of major holdings
29/1/202408:00UK RNSMaxCyte, Inc. Filing of Form 8-K
23/1/202419:39ALNCNewsTRADING UPDATES: Esken's Southend Airport faces further..

Dernières Valeurs Consultées

LSE
MXCT
Maxcyte
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés